NUVB · Categories · Form 4
NUVB - SEC Form 4 insider transactions
Nuvation Bio Inc. (NUVB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for NUVB
- SEC Form 4 filed by Director Vernon W Anthony4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Mashal Robert4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Falberg Kathryn E4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Blickenstaff Kim D4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Bazemore Robert B4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Cui Xiangmin4 - Nuvation Bio Inc. (0001811063) (Issuer)
- Amendment: SEC Form 4 filed by Director Cui Xiangmin4/A - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Wentworth Kerry4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Liu Dongfang4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Wentworth Kerry4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF MEDICAL OFFICER Liu Dongfang4 - Nuvation Bio Inc. (0001811063) (Issuer)
- Officer Makunje Moses was granted 50,761 shares, increasing direct ownership by 292% to 68,137 units (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF REGULATORY OFFICER Wentworth Kerry4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Sjogren Colleen4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sauvage Philippe4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF PEOPLE OFFICER Markel Stacy4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Cui Xiangmin4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hattersley Gary4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF TECHNICAL OPERATIONS Hanley David C.4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Hung David4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF MEDICAL OFFICER Liu Dongfang exercised 150,000 shares at a strike of $2.93 and sold $1,173,255 worth of shares (150,000 units at $7.82) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF MEDICAL OFFICER Liu Dongfang exercised 20,000 shares at a strike of $3.61 and sold $155,000 worth of shares (20,000 units at $7.75) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF SCIENTIFIC OFFICER Hattersley Gary exercised 369,051 shares at a strike of $1.90 and sold $2,667,132 worth of shares (369,051 units at $7.23) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF MEDICAL OFFICER Liu Dongfang exercised 20,000 shares at a strike of $1.87 and sold $140,074 worth of shares (20,000 units at $7.00) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF TECHNICAL OPERATIONS Hanley David C. exercised 200,000 shares at a strike of $1.87 and sold $1,427,680 worth of shares (200,000 units at $7.14) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF MEDICAL OFFICER Liu Dongfang exercised 30,000 shares at a strike of $1.87 and sold $148,028 worth of shares (30,000 units at $4.93), increasing direct ownership by 20% to 18,000 units (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF SCIENTIFIC OFFICER Hattersley Gary exercised 100,000 shares at a strike of $1.74 and sold $502,460 worth of shares (100,000 units at $5.02) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Mashal Robert4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Blickenstaff Kim D4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Falberg Kathryn E4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Vernon W Anthony4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Bazemore Robert B4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Mashal Robert4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CHIEF MEDICAL OFFICER Liu Dongfang exercised 20,000 shares at a strike of $1.94 and sold $50,024 worth of shares (20,000 units at $2.50) (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF REGULATORY OFFICER Wentworth Kerry4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Sjogren Colleen4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sauvage Philippe4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF PEOPLE OFFICER Markel Stacy4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Officer Makunje Moses4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF MEDICAL OFFICER Liu Dongfang4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Hung David4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hattersley Gary4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by CHIEF TECHNICAL OPERATIONS Hanley David C.4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CEO, ANHEART THERAPEUTICS LTD. Wang Junyuan Jerry sold $162,883 worth of shares (56,361 units at $2.89), decreasing direct ownership by 1% to 3,866,228 units (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sauvage Philippe4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Vernon W Anthony4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Falberg Kathryn E4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Blickenstaff Kim D4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Director Bazemore Robert B4 - Nuvation Bio Inc. (0001811063) (Issuer)
- CEO, ANHEART THERAPEUTICS LTD. Wang Junyuan Jerry converted options into 4,239,300 shares, increasing direct ownership by 184% to 3,922,589 units (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- Director Cui Xiangmin converted options into 19,004,200 shares (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- Welch Daniel G exercised 659,947 shares at a strike of $1.68 (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- Cui Xiangmin was granted 6,172,344 shares (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Sjogren Colleen4 - Nuvation Bio Inc. (0001811063) (Issuer)
- Wang Junyuan Jerry was granted 1,929,747 shares (SEC Form 4)4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Markel Stacy4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Wentworth Kerry4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Hanley David C.4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Hattersley Gary4 - Nuvation Bio Inc. (0001811063) (Issuer)
- SEC Form 4 filed by Liu Dongfang4 - Nuvation Bio Inc. (0001811063) (Issuer)